ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #7,611Hybrid

Journal of Gene Medicine

Acronym:jgm-wiley
•
Abbreviation (ISO):J. GENE MED
•
Identifier (ISSN):1099-498X(Print)/1521-2254(Online)
•
Publisher:John Wiley and Sons Ltd
Clarivate IF (2026)
3↑ +0.8
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Gene Medicine

WoS Q3
13461.6520181.5620193.2620204.5720214.1520223.520233.220242.2202532026
Annual Impact Factor Metric
Current (2026):3
Scopus SJR & RankScopus Q2
0.746
#7,611

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
104

104 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate3.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
84articles/year
15.38% Gold OA•89.83% Original Research

Aims & Scope

The aims and scope of The Journal of Gene Medicine include cutting-edge science of gene transfer and its applications in gene and cell therapy, genome editing with precision nucleases, epigenetic modifications of host genome by small molecules, siRNA, microRNA and other noncoding RNAs as therapeutic gene-modulating agents or targets, biomarkers for precision medicine, and gene-based prognostic/diagnostic studies. Key areas of interest are the design of novel synthetic and viral vectors, novel therapeutic nucleic acids such as mRNA, modified microRNAs and siRNAs, antagomirs, aptamers, antisense and exon-skipping agents, refined genome editing tools using nucleic acid /protein combinations, physically or biologically targeted delivery and gene modulation, ex vivo or in vivo pharmacological studies including animal models, and human clinical trials. Papers presenting research into the mechanisms underlying transfer and action of gene medicines, the application of the new technologies for stem cell modification or nucleic acid based vaccines, the identification of new genetic or epigenetic variations as biomarkers to direct precision medicine, and the preclinical/clinical development of gene/expression signatures indicative of diagnosis or predictive of prognosis are also encouraged.

Topics Covered (Recognized by AI)
Biology88.6%Genetics74.8%Chemistry73.6%Biochemistry72.3%Gene68.3%Medicine64.5%Internal medicine46.9%Molecular biology38.8%Cell culture36.6%Genetic enhancement34%Immunology33.1%Transfection27.1%Cell biology26.3%Recombinant DNA22.9%Computer science22.3%Computational biology20.2%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Q3
Rank102/180
IndexSCIE
JCRSCIE2026

GENETICS & HEREDITY

Q2
Rank80/192
IndexSCIE
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q3
Rank96/191
IndexSCIE
JCISCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Q3
Rank93/180
IndexSCIE
JCISCIE2026

GENETICS & HEREDITY

Q3
Rank97/192
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank89/191
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3
Articles / Year51
Total Citations10
2025
IF2.2
Articles / Year86
Total Citations147
2024
IF3.2
Articles / Year113
Total Citations536
2023
IF3.5
Articles / Year185
Total Citations1,269
2022
IF4.152
Articles / Year78
Total Citations535

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,611Scopus Q2SCImago Profile
Scopus Coverage:1998-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.746

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.89

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,103 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations925
3-Year Documents323
Citable Documents321

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ2
GeneticsQ2
Genetics (clinical)Q2
Molecular BiologyQ3
Molecular MedicineQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
3区BIOTECHNOLOGY & APPLIED MICROBIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Gene Medicine (acronym: jgm-wiley, abbr: J. GENE MED, ISSN: 1099-498X) is a peer-reviewed international scholarly journal in the field of Medicine, published by John Wiley and Sons Ltd in England since 1999. The periodical holds a Journal Impact Factor (JIF) of 3.00, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.746 (Q2), an H-index of 104.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 84 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,103 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
John Wiley and Sons Ltd
Publication Language
English
Frequency
Monthly
Founding Year
1999
Indexing & Databases
SCIEScopusPubMed
Editorial Address
JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 1365826d-4971-4d13-8b97-05e8dfc42831
Database Updated: 2026-09-28